Lord Abbett Health Care R3 (LHCQX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
23.00
-0.31 (-1.33%)
At close: Oct 16, 2026
LHCQX Holdings Information
LHCQX is a mutual fund with a total of 55 individual holdings. The top holdings are Eli Lilly and Company stock at 10.72%, UnitedHealth Group at 5.57%, Johnson & Johnson at 5.11%, Novartis AG at 4.32%, and Natera at 3.71%.
Total Holdings
55
Top 10 Percentage
44.28%
Asset Class
Equity
Fund Category
Health
Assets
8.74M
Forward PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 10.72% |
| 2 | UNH | UnitedHealth Group Incorporated | 5.57% |
| 3 | JNJ | Johnson & Johnson | 5.11% |
| 4 | SWX: NOVN | Novartis AG | 4.32% |
| 5 | NTRA | Natera, Inc. | 3.71% |
| 6 | GILD | Gilead Sciences, Inc. | 3.64% |
| 7 | CVS | CVS Health Corporation | 3.44% |
| 8 | GH | Guardant Health, Inc. | 2.69% |
| 9 | SWX: GALD | Galderma Group AG | 2.68% |
| 10 | TMO | Thermo Fisher Scientific Inc. | 2.39% |
| 11 | COGT | Cogent Biosciences, Inc. | 2.34% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.31% |
| 13 | TXG | 10x Genomics, Inc. | 2.23% |
| 14 | HKG: 6160 | BeOne Medicines AG | 2.12% |
| 15 | ASND | Ascendis Pharma A/S | 2.05% |
| 16 | LON: AZN | AstraZeneca PLC | 2.03% |
| 17 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.97% |
| 18 | BBIO | BridgeBio Pharma, Inc. | 1.90% |
| 19 | EW | Edwards Lifesciences Corporation | 1.84% |
| 20 | RVMD | Revolution Medicines, Inc. | 1.73% |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.57% |
| 22 | PTGX | Protagonist Therapeutics, Inc. | 1.49% |
| 23 | DNTH | Dianthus Therapeutics, Inc. | 1.48% |
| 24 | ADPT | Adaptive Biotechnologies Corporation | 1.47% |
| 25 | EBR: ARGX | argenx SE | 1.47% |
As of Jul 31, 2026